Sulfide is a substrate and inhibitor of myeloperoxidase

E-ISSN： 1476-5381|172|6|1516-1532

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.6, 2015-03, pp. : 1516-1532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukocyte myeloperoxidase and pathogenesis of the post-polio syndrome

By Movitz Charlotta Bergström Tomas Borg Kristian Hellstrand Kristoffer Lycke Erik Lycke Jan

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 11-12, 2010-12 ,pp. : 958-960

Informa Healthcare

Access to resources Recommend Favorite

NADPH OXIDASE AND MYELOPEROXIDASE ACTIVITY IN PSORIASIS LEUKOCYTES

THE JOURNAL OF DERMATOLOGY, Vol. 12, Iss. 5, 1985-10 ,pp. : 425-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

Consequences of Total and Subtotal Myeloperoxidase Deficiency: Risk or Benefit ?

Acta Haematologica, Vol. 104, Iss. 1, 2000-11 ,pp. : 10-15

Karger

Access to resources Recommend Favorite

Myeloperoxidase Directs Properdin-Mediated Complement Activation

Journal of Innate Immunity, Vol. 6, Iss. 4, 2013-12 ,pp. : 417-425

Karger

Access to resources Recommend Favorite

Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1012-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite